Gregory T. Carter

5.3k total citations
135 papers, 3.4k citations indexed

About

Gregory T. Carter is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Gregory T. Carter has authored 135 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Neurology, 36 papers in Cellular and Molecular Neuroscience and 33 papers in Pharmacology. Recurrent topics in Gregory T. Carter's work include Amyotrophic Lateral Sclerosis Research (32 papers), Muscle Physiology and Disorders (23 papers) and Genetic Neurodegenerative Diseases (21 papers). Gregory T. Carter is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (32 papers), Muscle Physiology and Disorders (23 papers) and Genetic Neurodegenerative Diseases (21 papers). Gregory T. Carter collaborates with scholars based in United States, Spain and United Kingdom. Gregory T. Carter's co-authors include Richard T. Abresch, Mark P. Jensen, Craig M. McDonald, Michael D. Weiss, David D. Kilmer, Patrick Weydt, Jay J. Han, Nanette C. Joyce, Sunil Aggarwal and George H. Kraft and has published in prestigious journals such as Neurology, Human Molecular Genetics and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Gregory T. Carter

126 papers receiving 3.3k citations

Peers

Countries citing papers authored by Gregory T. Carter

Since Specialization

Citations

This map shows the geographic impact of Gregory T. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory T. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory T. Carter more than expected).

Fields of papers citing papers by Gregory T. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory T. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory T. Carter. The network helps show where Gregory T. Carter may publish in the future.

Co-authorship network of co-authors of Gregory T. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory T. Carter. A scholar is included among the top collaborators of Gregory T. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory T. Carter. Gregory T. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications 2025 ·Muscle & Nerve ·Travis T. Denton, Gregory T. Carter, Moses Goddard, Jeremy C. Weiss, Douglas L. Weeks, Patrick Weydt, Ethan B. Russo, Michael D. Weiss	0
2	ALSUntangled #66: antimycobacterial antibiotics. 2022 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ellen S. Pierce, Paul E. Barkhaus, (unknown), Mark B. Bromberg, Gregory T. Carter, (unknown), David Greeley, (unknown), (unknown), Isaac Lund, Christopher McDermott, Gary L. Pattee, (unknown), Meraida Polak, (unknown), Paul Wicks, Richard Bedlack	1
3	Rehabilitation Management in Neuromuscular Disease 2019 ·Gregory T. Carter	4
4	Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State 2018 ·Journal of Opioid Management ·Sunil Aggarwal, Gregory T. Carter, Mark D. Sullivan, Craig ZumBrunnen, Richard L. Morrill, Jonathan D. Mayer	29
5	Pilot Randomized Trial Comparing Intersession Scheduling of Biofeedback Results to Individuals with Chronic Pain 2015 ·American Journal of Physical Medicine & Rehabilitation ·Douglas L. Weeks, (unknown), (unknown), Gregory T. Carter	14
6	Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy 2015 ·Human Molecular Genetics ·(unknown), Ewa Stępniak-Konieczna, (unknown), Jessica Wei, Gregory T. Carter, Michael D. Weiss, Joel R. Chamberlain	42
7	Charcot‐Marie‐Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies 2014 ·PM&R ·(unknown), John D. England, Gregory T. Carter	32
8	Pediatric Rehabilitation 2014 ·Physical Medicine and Rehabilitation Clinics of North America ·Gregory T. Carter	0
9	Electrodiagnosis in Persons With Amyotrophic Lateral Sclerosis 2013 ·PM&R ·Nanette C. Joyce, Gregory T. Carter	43
10	Symptom Burden in Persons with Myotonic and Facioscapulohumeral Muscular Dystrophy 2013 ·American Journal of Physical Medicine & Rehabilitation ·Amanda Smith, Kara McMullen, Mark P. Jensen, Gregory T. Carter, Ivan Molton	19
11	Disease Burden in Neuromuscular Disease 2012 ·Physical Medicine and Rehabilitation Clinics of North America ·Gregory T. Carter, Jordi Miró, Richard T. Abresch, (unknown), Mark P. Jensen	14
12	Skeletal Muscle Edema in Muscular Dystrophy: Clinical and Diagnostic Implications 2011 ·Physical Medicine and Rehabilitation Clinics of North America ·Sandra L. Poliachik, Seth D. Friedman, Gregory T. Carter, Shawn E. Parnell, Dennis Shaw	22
13	Aging with Muscular Dystrophy: Pathophysiology and Clinical Management 2010 ·Physical Medicine and Rehabilitation Clinics of North America ·Gregory T. Carter, Michael D. Weiss, Joel R. Chamberlain, Jay J. Han, Richard T. Abresch, Jordi Miró, Mark P. Jensen	5
14	The Amyotrophic Lateral Sclerosis Center: A Model of Multidisciplinary Management 2008 ·Physical Medicine and Rehabilitation Clinics of North America ·(unknown), Michael D. Weiss, B. Jane Distad, Lisa S. Krivickas, Gregory T. Carter	27
15	Clinical features of late‐onset Pompe disease: A prospective cohort study 2008 ·Muscle & Nerve ·John H. J. Wokke, Diana M. Escolar, Alan Pestronk, Kenneth M. Jaffe, Gregory T. Carter, Leonard H. van den Berg, Julaine Florence, J. Mayhew, Alison Skrinar, Deyanira Corzo, Pascal Laforêt	132
16	Physiological and Anatomical Basis of Muscle Magnetic Resonance Imaging 2005 ·Physical Medicine and Rehabilitation Clinics of North America ·Russell C. Fritz, (unknown), Gregory T. Carter	7
17	Chronic Pain in Persons with Neuromuscular Disease 2005 ·Physical Medicine and Rehabilitation Clinics of North America ·Amy J. Hoffman, Mark P. Jensen, Richard T. Abresch, Gregory T. Carter	27
18	Electrodiagnostic evaluation of hereditary motor and sensory neuropathies 2003 ·Physical Medicine and Rehabilitation Clinics of North America ·Gregory T. Carter, John D. England, T. Hecht, Jay J. Han, Patrick Weydt, Phillip F. Chance	4
19	Marijuana in the management of amyotrophic lateral sclerosis 2001 ·American Journal of Hospice and Palliative Medicine® ·Gregory T. Carter, (unknown)	40
20	Pursed lips breathing improves ventilation in myotonic muscular dystrophy 2000 ·Archives of Physical Medicine and Rehabilitation ·Viviane Ugalde, Eileen Hanafin Breslin, Sandra A. Walsh, H. William Bonekat, Richard T. Abresch, Gregory T. Carter	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact